ACR Meeting Abstracts

ACR Meeting Abstracts

Session » Abstracts: RA – Treatments II: New Findings in Established Therapies (1442–1445)

Date: Monday, November 8, 2021

Time: 2:00PM-3:00PM

Meeting: ACR Convergence 2021

Abstract Number: 1442
Effectiveness of Cycling JAKi Compared to Switching to bDMARD in Patients Who Failed a First JAKi in an International Collaboration of Registries of Rheumatoid Arthritis Patients (the JAK-pot Study)
Abstract Number: 1443
Long-term Effectiveness of Ultra-Low Doses of Rituximab in Rheumatoid Arthritis
Abstract Number: 1444
Baseline Factors Associated with the Development of Nausea and Alopecia over One Year in Patients Starting Methotrexate for Rheumatoid Arthritis
Abstract Number: 1445
Association Between Baseline Use of Rituximab and COVID-19 Outcomes in Patients with Rheumatoid Arthritis (RA)

« View all sessions from this meeting